PHARMACEUTICAL RESEARCH

Pharmaceutical Research

Pharmaceutical Research Services

Research studies are designed to test the effect of a drug or treatment in a group of volunteers, measure the ability of a drug to treat a medical condition, and monitor drug safety and possible side effects.
In our clinic we have extensive experience in drug trials. We support the development of new innovative medicines to improve the health of patients.

If you are interested on any of the following studies please contact us NOW, we are here to answer any questions you may have.

Cancer Screening Collection Study

Lung Cancer xray

Cohort A - Lung Cancer Screening

Subjects will complete 3 Visits (1 visit per year). Subjects will receive $200.00 per visit ($100 at screening and $100 after completing the CT scan). CT scans are free.

This protocol is designed to prospectively collect peripheral blood samples, general medical record information including demographics and medical history as well as cancer screening outcomes and any cancer diagnosis confirmed during study participation. 

Inclusion Criteria  

  1. Women and men 50–80 years at high-risk for development of lung cancer as below:  
    1. Current or previous smokers.
  2. Willing and able to provide peripheral blood samples. 

Cohort B - Colorectal Cancer Screening

Subjects will complete 3 Visits (1 visit per year). Subjects will receive $200.00 per visit. Colonoscopy should be completed within 90 days after blood collection at the Baseline Visit. Colonoscopy may be ordered by the PCP.

This protocol is designed to prospectively collect peripheral blood samples and participant demographic and clinical information from eligible and consented individuals.

Inclusion Criteria: 

  1. Women and men 45–85 years of age eligible for CRC screening.
  2. Willing and able to undergo optical colonoscopy and within approximately 90 days from the date of enrollment blood draw.
picture with two women talking

Do you have high triglycerides or atherosclerotic cardiovascular disease?

Learn about the Essence clinical research study.
This study is researching olezarsen (ISIS 678354), an investigational* medication that may help lower triglycerides (fats in the blood) in people with high triglycerides or atherosclerotic cardiovascular disease. Other study requirements apply.

  1. *Olezarsen is only approved for use in clinical studies.
    Study participants receive at no cost:
    • Possible access to a new study medication, taken as an injection once every 4 weeks • 1 out of 4 participants will be randomly assigned to receive placebo, which has
    no active ingredients
    • Study support and monitoring by a healthcare team
    • Health assessments and dietary counseling
    • Education about high triglycerides and atherosclerotic cardiovascular disease
  2. Option to complete some study visits at home
    • Opportunity to help advance clinical research
    For more information, contact us.

Do you have COPD?

If so, perhaps you can join the TRITON Study and possibly help find better treatment options for future sufferers of COPD
Study participation is at no charge, and compensation for time and travel expenses may be available to those who satisfy applicable requirements.

To join the TRITON Study potential participants must:

  • Be a current or ex-smoker at least 40 years of age
  • Have been diagnosed with COPD for at least one year
  • Require daily medication to control their COPD symptoms

Quick Contact

    Picture of pharmaceutical pills

    Discovering Innovative Solutions for Better Health

    As a healthcare provider, we work seamlessly and in unison with the pharmaceutical industry, to provide innovative clinical practices and research, conducive to promoting our primary focus, “safe patient care.”

    0

    Checkup History

    0

    Satisfied Patients